Disc Medicine director Mona Ashiya resigns; board reduced to eight members

Disc Medicine, Inc.

Mona Ashiya, Ph.D., resigned as Class I director effective October 3, 2025.
She also left the Compensation and Nominating/Corporate Governance Committees.
Resignation was not due to any disagreement with the Company.
Board size decreased from nine to eight members.

item 5.02

Disc Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-231911

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.